Company intelligence / Profile preview

Morris Innovative

Bloomington, Indiana, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

Morris Innovative has developed and commercialized the Femoral Introducer Sheath & Hemostasis Device (FISH™), an FDA-approved vascular closure device that utilizes small intestinal submucosa (SIS®) as a biologic scaffold to seal arterial access sites after catheterization. The FISH™ device is designed to reduce scar tissue, inflammation, and infection risk while improving patient comfort by combining vessel access and closure into one step.

Therapeutic areas: Cardiovascular
Modalities: DeviceBiologic
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Morris Innovative.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morris Innovative.

Explore the full profile